Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. K. (Kevin) Damman

Research interests

Kevin Damman is clinical cardiologist and head of the heart transplant and left ventricular assist device program at the University Medical Center Groningen. His research focuses on acute and advanced heart failure, with particular emphasis on the cardiorenal axis. Current research interests are focused on improving treatment of acute heart failure patients, including early assessment of effect of decongestive therapies, SGLT2-inhibition in (acute) heart failure and the role of the kidney in the process of cardiorenal interaction. He is principle investigator of the EMPA-RESPONSE-AHF study  on empagliflozin in acute heart failure and is part of the steering committee of the ADVOR trial investigating acetazolamide in acute heart failure. Dr Damman is associate editor of the European Journal of Heart Failure and serves as official European Society of Cardiology (ESC) Journals Twitter editor. Furthermore, he is member of the working groups on Cardiorenal Dysfunction and Acute Heart Failure from the Heart Failure Association of the ESC.

Publications

Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)

Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology

Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients

Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients

Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Added value of semi-quantitative analysis of [18F]FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device

Albuminuria as a marker of systemic congestion in patients with heart failure( )

Cardiogenic shock due to probable SARS-CoV-2 myocarditis: a case report

Cardiorenal interactions in heart failure - insights from recent therapeutic advances

Changes in the Inferior Vena Cava Are More Sensitive Than Venous Pressure During Fluid Removal: A Proof-of-Concept Study

Read more

Press/media

Tegelijkertijd nieuw hart én nieuwe lever voor patiënte in Groningen

Hoe blijft chirurg 12 uur scherp? 'Ik drink alleen water'

Acetazolamide in de behandeling van acuut hartfalen

SGLT2-remmers bij HFrEF: praktische adviezen bij eGFR-daling

Nierfunctie, elektrolyten en hartfalen

Nonsteroidal MRA Drug Cuts Risks in Earlier Diabetic Kidney Disease

CV uitkomsten met niet-steroïde MRA in patiënten met diabetes en nierschade

Read more